Glenmede Trust CO Na Cyto Dyn Inc. Transaction History
Glenmede Trust CO Na
- $19.6 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding CYDY
# of Institutions
12Shares Held
271KCall Options Held
0Put Options Held
0-
Diversified Trust CO45.8KShares$7,3260.0% of portfolio
-
Virtue Capital Management, LLC Brentwood, TN45KShares$7,2000.0% of portfolio
-
Mai Capital Management42.5KShares$6,7970.0% of portfolio
-
Moloney Securities Asset Management, LLC28KShares$4,4840.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY25KShares$4,0000.0% of portfolio
About CytoDyn Inc.
- Ticker CYDY
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 813,040,000
- Market Cap $130M
- Description
- CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...